ImmunityBio, Inc. — Investor Relations & Filings
ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies and vaccines designed to strengthen a patient's own immune system. The company's approach focuses on orchestrating both the innate (natural killer cells) and adaptive (T cells) immune systems to combat cancer and infectious diseases. Its key platforms include the IL-15 superagonist Anktiva® (N-803), engineered natural killer (NK) cell therapies, and adenovirus-vectored vaccines. These therapies are being investigated and applied across a range of difficult-to-treat cancers, such as bladder, lung, and pancreatic cancers, as well as infectious diseases like HIV. The company's goal is to create durable, complete responses by treating the host's immune system rather than just the disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-05-07 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-09 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-04-06 | English | |
| 8-K - ImmunityBio, Inc. (0001326110) (Filer) | 2026-03-31 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Camp4 Therapeutics Corp
Develops RNA-based therapeutics to amplify protein expressi…
|
CAMP | US | Manufacturing |
|
Camurus
Develops and commercializes long-acting medicines for sever…
|
CAMX | SE | Manufacturing |
|
CANbridge Pharmaceuticals Inc.
Global biopharma developing and commercializing transformat…
|
1228 | KY | Manufacturing |
|
Candel Therapeutics, Inc.
Develops viral immunotherapies to activate the immune syste…
|
CADL | US | Manufacturing |
|
Can-Fite BioPharma Ltd.
Clinical-stage biopharma developing oral small-molecule dru…
|
CANF | IL | Manufacturing |
|
Cangene Corporation
Biopharma focused on developing and manufacturing plasma-de…
|
CNJ | CA | Manufacturing |
|
Cannabotech Ltd.
Develops therapies by integrating cannabinoids and medicina…
|
CNTC | IL | Manufacturing |
|
Cannara Biotech Inc.
Large-scale, low-cost producer of premium cannabis products…
|
LOVE | CA | Manufacturing |
|
Cannex Capital Holdings Inc.
Operated across the entire cannabis value chain, producing …
|
CNNX | CA | Manufacturing |
|
CANN GROUP LIMITED
Cultivates, manufactures, and supplies pharmaceutical-grade…
|
CAN | AU | Manufacturing |
ImmunityBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31529/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31529 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31529 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31529 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31529}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ImmunityBio, Inc. (id: 31529)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.